Log In
BCIQ
Print this Print this
 

OXY2810

  Manage Alerts
Collapse Summary General Information
Company Oxyrane U.K. Ltd.
DescriptionRecombinant human acid alpha glucosidase enzyme (rhGAA)
Molecular Target Acid alpha glucosidase (GAA)
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationPompe's disease
Indication DetailsTreat Pompe's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today